drugset / Trial / NCT04440371
Phototherapy Combination With Topicals in Vitiligo
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients will be included in a randomized controlled clinical trial, will enroll only adult vitiligo patients with surface area of at least 10% who are being followed in the outpatient dermatology clinics of King Abdullah University Hospital (KAUH) and are planned to start on phototherapy Narrow Band Ultraviolet light B (NBUVB), regardless if they have previous treatment for their disease, one month wash off period will be given for patients who are already on phototherapy or other treatments for vitiligo.
Timeline
- Start
- 2020-06-21
- Primary completion
- 2023-07-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Betamethasone | Other / unclassified | — | Topical |
| Subject | Calcipotriol | Small molecule | — | Topical |
| Subject | Tacrolimus | Small molecule | 0.1 % | Topical |